Production and characterization of LEA29Y, a variant of cytotoxic T-lymphocyte antigen 4-immunoglobulin, in Pichia pastoris

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Applied Microbiology and Biotechnology

• Publication date

  2011-04-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00253-011-3277-4PMID 21533579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)

  2010cited by this paper
• Sialylation enhancement of CTLA4‐Ig fusion protein in Chinese hamster ovary cells by dexamethasone

  2010cited by this paper
• Five-year safety and efficacy of belatacept in renal transplantation.

  2010cited by this paper
• A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

  2010cited by this paper
• Expression of recombinant proteins in the methylotrophic yeast Pichia pastoris.

  2010cited by this paper
• Advances in immunosuppression for renal transplantation

  2010cited by this paper
• Current strategies for the treatment of autoimmune diseases.

  2010cited by this paper
• New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting

  2009cited by this paper
• Production of recombinant proteins by microbes and higher organisms.

  2009cited by this paper
• CD28 and CTLA‐4 coreceptor expression and signal transduction

  2009cited by this paper
• The clinical utility of inhibiting CD28‐mediated costimulation

  2009cited by this paper
• Establishment of Long-Term Tolerance to SRBC in Dogs by Recombinant Canine CTLA4-Ig

  2009cited by this paper
• Costimulatory pathways in transplantation: challenges and new developments

  2009cited by this paper
• Expression in the yeast Pichia pastoris.

  2009cited by this paper
• Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology

  2008cited by this paper
• Cloning, expression and bioassay of canine CTLA4Ig.

  2007cited by this paper
• The glycosylation and pharmacokinetics of CTLA4Ig produced in rice cells.

  2007cited by this paper
• Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes.

  2007cited by this paper
• Process Technology for Production and Recovery of Heterologous Proteins with Pichia pastoris

  2006cited by this paper
• Strategic opportunities in clinical islet transplantation.

  2005cited by this paper
• Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties

  2005influential reference
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates.

  2002cited by this paper
• CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells.

  2001cited by this paper
• Recombinant protein expression in Pichia pastoris

  2000cited by this paper
• Modeling Pichia pastoris growth on methanol and optimizing the production of a recombinant protein, the heavy-chain fragment C of botulinum neurotoxin, serotype A.

  2000cited by this paper
• Mitogenic stimulation of T cells reveals differing contributions for B7‐1 (CD80) and B7‐2 (CD86) costimulation

  1997cited by this paper
• CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.

  1996cited by this paper
• Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1

  1993cited by this paper
• T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.

  1992cited by this paper
• Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

  1992cited by this paper
• CTLA-4 is a second receptor for the B cell activation antigen B7

  1991cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• A trimeric immunoglobin G-binding domain outperforms recombinant protein G and protein L as a ligand for fragment antigen-binding purification.

  2022cites this paper
• Structure Prediction and Expression of Modified rCTLA4-Ig as a Blocker for B7 Molecules

  2020cites this paper
• Recombinant expression, characterization, and application of a phospholipase B from Fusarium oxysporum.

  2017influential citation
• Cloning and high level expression of the biologically active extracellular domain of Macaca mulatta CD40 in Pichia pastoris.

  2016cites this paper
• A xylanase from Streptomyces sp. FA1: heterologous expression, characterization, and its application in Chinese steamed bread

  2016cites this paper
• ON EPSTEIN-BARR VIRUS ACTIVATION IN LYMPHOID AND EPITHELIAL CANCER CELLS

  2016cites this paper
• Production and characterization of human soluble CD83 fused with the fragment crystallizable region of human IgG1 in Pichia pastoris

  2013influential citation
• Production and characterization of a CD25-specific scFv-Fc antibody secreted from Pichia pastoris

  2012cites this paper
• Current world literature.

  2012cites this paper